CDKN2B-AS1 and nasopharyngeal carcinoma: In agreement, silencing ANRIL can inhibit the proliferation and promote the apoptosis of nasopharyngeal carcinoma cells through up-regulation of its target gene let-7a, eventually improving the chemosensitivity to cisplatin, as reported by Dong J et al. [32].